Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AOTGNASDAQ:FDFFNASDAQ:FMEDNASDAQ:HRTS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAOTGAOT Growth & Innovation ETF$46.55-0.5%$43.79$32.95▼$48.40$53.46M-1.841,464 shs167 shsFDFFFidelity Disruptive Finance ETF$36.54-0.8%$36.21$29.09▼$39.78$47.50M1.424,868 shs11,014 shsFMEDFidelity Disruptive Medicine ETF$23.28-0.3%$23.42$20.69▼$26.79$48.89M1.035,761 shs2,878 shsHRTSTema GLP-1, Obesity & Cardiometabolic ETF$27.98-1.0%$27.97$25.32▼$36.03$53.16M0.939,815 shs3,247 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAOTGAOT Growth & Innovation ETF-0.55%+0.83%+2.10%+12.78%+22.27%FDFFFidelity Disruptive Finance ETF-0.85%-1.26%-0.72%+3.47%+23.51%FMEDFidelity Disruptive Medicine ETF-0.32%-1.79%+0.39%-5.02%-0.64%HRTSTema GLP-1, Obesity & Cardiometabolic ETF-1.03%-2.88%+1.89%-6.67%-13.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAOTGAOT Growth & Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/AFDFFFidelity Disruptive Finance ETFN/AN/AN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAOTGAOT Growth & Innovation ETF 2.75Moderate Buy$46.55N/AFDFFFidelity Disruptive Finance ETF 2.68Moderate Buy$36.54N/AFMEDFidelity Disruptive Medicine ETF 2.84Moderate Buy$23.28N/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF 2.76Moderate Buy$27.98N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAOTGAOT Growth & Innovation ETFN/AN/AN/AN/AN/AN/AFDFFFidelity Disruptive Finance ETFN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAOTGAOT Growth & Innovation ETFN/AN/A37.66∞N/AN/AN/AN/AN/AFDFFFidelity Disruptive Finance ETFN/AN/A22.71∞N/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/A37.99∞N/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/A24.84∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAOTGAOT Growth & Innovation ETFN/AN/AN/AN/AN/AFDFFFidelity Disruptive Finance ETF$0.260.71%N/AN/AN/AFMEDFidelity Disruptive Medicine ETF$0.110.47%N/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF$0.461.64%N/AN/AN/ALatest FDFF, AOTG, FMED, and HRTS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/20/2025FDFFFidelity Disruptive Finance ETFQuarterly$0.16106/20/20256/20/20256/24/20253/21/2025FDFFFidelity Disruptive Finance ETF$0.03503/21/20253/21/20253/25/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAOTGAOT Growth & Innovation ETFN/AFDFFFidelity Disruptive Finance ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AInsider OwnershipCompanyInsider OwnershipAOTGAOT Growth & Innovation ETFN/AFDFFFidelity Disruptive Finance ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAOTGAOT Growth & Innovation ETFN/A1.15 millionN/ANot OptionableFDFFFidelity Disruptive Finance ETFN/A1.30 millionN/ANot OptionableFMEDFidelity Disruptive Medicine ETFN/A2.10 millionN/ANot OptionableHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/A1.90 millionN/AN/AFDFF, AOTG, FMED, and HRTS HeadlinesRecent News About These CompaniesWeight-Loss Drug ETFs Generate Skinnier Returns Than ExpectedJune 11, 2025 | finance.yahoo.comWhen the Price of (HRTS) Talks, People ListenFebruary 12, 2025 | news.stocktradersdaily.com(HRTS) Trading SignalsJanuary 31, 2025 | news.stocktradersdaily.comHow to Take Advantage of moves in (HRTS)January 21, 2025 | news.stocktradersdaily.comNew Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFsJanuary 17, 2025 | etftrends.com(HRTS) Technical DataDecember 20, 2024 | news.stocktradersdaily.comDisruptive Theme of the Week – Breakthroughs in MedicineNovember 21, 2024 | etftrends.com(HRTS) Investment AnalysisNovember 18, 2024 | news.stocktradersdaily.com(HRTS) Pivots Trading Plans and Risk ControlsNovember 8, 2024 | news.stocktradersdaily.comLearn to Evaluate (HRTS) using the ChartsOctober 28, 2024 | news.stocktradersdaily.comHRT may help to protect the heartOctober 22, 2024 | dailymail.co.ukInside the Booming Obesity Drug Market: Weight Loss ETFs to WinOctober 16, 2024 | zacks.comInvesting in Real Assets: The Growing Demand and Opportunity with Brompton’s BREA ETFOctober 10, 2024 | theglobeandmail.comOil Prices Spike Amid Middle East TensionsOctober 8, 2024 | theglobeandmail.comGuardian Capital LP Launches Two New ETFs on CBOE CanadaOctober 8, 2024 | theglobeandmail.comWhen (HRTS) Moves Investors should ListenOctober 6, 2024 | news.stocktradersdaily.comHow does hormone therapy affect cardiovascular health, insulin resistance?September 29, 2024 | medicalnewstoday.com(HRTS) Proactive StrategiesSeptember 25, 2024 | news.stocktradersdaily.comHigh temperatures and factors such as obesity ‘driving global rises in stroke’September 18, 2024 | msn.comTap the Weight-Loss Drug Market With These ETFsSeptember 18, 2024 | zacks.comMedia Sentiment Over TimeFDFF, AOTG, FMED, and HRTS Company DescriptionsAOT Growth & Innovation ETF NASDAQ:AOTG$46.48 -0.32 (-0.67%) As of 06/20/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The AOT Growth and Innovation ETF (AOTG) is an exchange-traded fund that mostly invests in total market equity. The fund actively invests in a growth portfolio of low marginal cost companies in the US. Stocks are selected based on proprietary fundamental research and criteria. AOTG was launched on Jun 29, 2022 and is managed by Alpha Architect.Fidelity Disruptive Finance ETF NASDAQ:FDFF$36.53 -0.31 (-0.83%) Closing price 06/20/2025 03:38 PM EasternExtended Trading$36.53 0.00 (0.00%) As of 06/20/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Finance ETF (FDFF) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that invests in disruptive finance companies. These are organizations in the finance industry that are pushing for innovative developments that may significantly alter the way they deliver their products and services FDFF was launched on Apr 16, 2020 and is managed by Fidelity.Fidelity Disruptive Medicine ETF NASDAQ:FMED$23.28 -0.06 (-0.26%) Closing price 06/20/2025 03:58 PM EasternExtended Trading$23.28 -0.01 (-0.02%) As of 06/20/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Tema GLP-1, Obesity & Cardiometabolic ETF NASDAQ:HRTS$27.98 -0.29 (-1.03%) As of 06/20/2025 03:54 PM EasternThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
